Scott G M, Secher D S, Flowers D, Bate J, Cantell K, Tyrrell D A
Br Med J (Clin Res Ed). 1981 Apr 25;282(6273):1345-8. doi: 10.1136/bmj.282.6273.1345.
The effects of partially purified human leucocyte interferon (PIF) and of a preparation purified by passage twice through a monoclonal antibody affinity chromatography column (NK21F) were compared with those of a control solution in healhty volunteers. After intramuscular injections both interferon preparations caused rises in pulse rate and body temperature, changes in circulating white cell counts, and various unpleasant symptoms, the most common of which were headache, malaise, and fever. Slightly lower doses of NK21F were given, and this was reflected in lower peak serum concentrations. Mean symptom scores, however, were not lower after NK21F than after PIF. Local inflammatory reactions eight hours after intradermal inoculations of these interferons were similar. Purification of interferon using a monoclonal antibody does not reduce the facets of its activity considered in this study. They are therefore inherent in the leucocyte interferon type selected by the antibody.
在健康志愿者中,将部分纯化的人白细胞干扰素(PIF)以及经两次通过单克隆抗体亲和层析柱纯化的制剂(NK21F)的效果与对照溶液的效果进行了比较。肌内注射后,两种干扰素制剂均导致脉搏率和体温升高、循环白细胞计数变化以及各种不适症状,其中最常见的是头痛、不适和发热。给予NK21F的剂量略低,这反映在血清峰值浓度较低。然而,NK21F后的平均症状评分并不低于PIF后的评分。皮内接种这些干扰素8小时后的局部炎症反应相似。使用单克隆抗体纯化干扰素并不会降低本研究中所考虑的其活性方面。因此,它们是该抗体所选择的白细胞干扰素类型所固有的。